首页> 外国专利> .ALPHA.AED AND .BETA.AED REGULATION OF NUCLEAR TRANSCRIPTION, GENE REGULATION, AND/OR GENE EXPRESSION

.ALPHA.AED AND .BETA.AED REGULATION OF NUCLEAR TRANSCRIPTION, GENE REGULATION, AND/OR GENE EXPRESSION

机译:阿尔法和贝塔对核转录,基因调节和/或基因表达的调节

摘要

The present invention provides a means to regulate nuclear transcriptionand/or gene expression. The present invention also provides a means toregulate the levels of PPAR-.gamma., COX-2 and/or NF.kappa.B in a patient. Themethod of the present invention involves administering .alpha.AED (or ananalogue thereof) or .beta.AED (or an analogue thereof) or both to a patientin need of regulation of nuclear transcription and/or gene expression and/orlevels of PPAR-.gamma., COX-2, and/or NF.kappa.B. The methods of the presentinvention can be used to control adipogenesis (i.e. to treat obesity),angiogenesis, atherosclerosis, mesenteric fat hypertrophy, inflammatory boweldisease, colitis, Alzheimer's disease, and inflammatory glial responses in thebrain. The methods of the present invention can also be used for treatingdiabetes, for regulating the immune response, and for regulating inflammationin a patient.
机译:本发明提供了调节核转录的手段和/或基因表达。本发明还提供了一种用于调节患者体内PPAR-γ,COX-2和/或NF-κB的水平。的本发明的方法涉及施用αAED(或类似物)或βAED(或其类似物)或两者需要调节核转录和/或基因表达和/或PPAR-γ,COX-2和/或NF-κB的水平。目前的方法本发明可用于控制脂肪形成(即治疗肥胖),血管生成,动脉粥样硬化,肠系膜肥大,炎症性肠疾病,结肠炎,阿尔茨海默氏病和炎症性神经胶质反应脑。本发明的方法也可以用于治疗糖尿病,用于调节免疫反应和调节炎症在一个病人。

著录项

  • 公开/公告号CA2483258A1

    专利类型

  • 公开/公告日2003-10-02

    原文格式PDF

  • 申请/专利权人 LORIA ROGER M.;

    申请/专利号CA20032483258

  • 发明设计人 LORIA ROGER M.;

    申请日2003-03-21

  • 分类号A61K31/56;

  • 国家 CA

  • 入库时间 2022-08-21 23:57:55

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号